Wednesday, June 15, 2005
Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
Patent: Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
Wonder if it's the SansRosa guys?
Whatever, lets hope these type of developments are actually being formulated into products!
Hat-tip to GJ from forum.rosaceagroup.org for spotting the patent
Quote:
"The present invention relates to a method of treating, reducing, inhibiting, preventing and/or reversing cutaneous facial flushing caused by abnormal, endogenously-induced vasomotor instability associated with, but not limited to acne rosacea, menopause-associated hot flashes, hot flashes resulting from orchiectomy or ingestion of substances capable of inducing a cutaneous facial flushing reaction (e.g.: alcohol, chocolate, spices) by topical dermatological application of an effective dose of a composition comprising at least one .alpha..sub.2 adrenergic receptor agonist (such as a (2-imidazolin-2-ylamino) quinoxaline derivative such as brimonidine tartrate)and a suitable carrier.
Inventors: Scherer, Warren J.; (Naples, FL)"
The inventor appears to be an opthamologist from Florida, Dr. Warren J. Scherer.
Wonder if it's the SansRosa guys?
Whatever, lets hope these type of developments are actually being formulated into products!
Hat-tip to GJ from forum.rosaceagroup.org for spotting the patent
Quote:
"The present invention relates to a method of treating, reducing, inhibiting, preventing and/or reversing cutaneous facial flushing caused by abnormal, endogenously-induced vasomotor instability associated with, but not limited to acne rosacea, menopause-associated hot flashes, hot flashes resulting from orchiectomy or ingestion of substances capable of inducing a cutaneous facial flushing reaction (e.g.: alcohol, chocolate, spices) by topical dermatological application of an effective dose of a composition comprising at least one .alpha..sub.2 adrenergic receptor agonist (such as a (2-imidazolin-2-ylamino) quinoxaline derivative such as brimonidine tartrate)and a suitable carrier.
Inventors: Scherer, Warren J.; (Naples, FL)"
The inventor appears to be an opthamologist from Florida, Dr. Warren J. Scherer.
